Shelter Pharma (BOM:543963) DeferredTaxAndRevenue: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543963 Shelter Pharma Ltd BOM:543963
69 GF Score
Price ₹33.77
GF Value ₹57.30
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Shelter Pharma DeferredTaxAndRevenue?

Shelter Pharma BOM:543963 +5.53% 69 DeferredTaxAndRevenue is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:543963 with a GF Score™ of 69/100 and a GF Value™ of ₹57.30 (Possible Value Trap). The stock has 5 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Shelter Pharma's current deferred tax and revenue for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

Shelter Pharma DeferredTaxAndRevenue Related Terms

Shelter Pharma DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Shelter Pharma's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shelter Pharma DeferredTaxAndRevenue Chart

Shelter Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
DeferredTaxAndRevenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Shelter Pharma Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:543963
69GF Score
Shelter Pharma Ltd BOM:543963
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of ₹0.0 Mil mean?
Shelter Pharma (BOM:543963) has a DeferredTaxAndRevenue of ₹0.0 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Shelter Pharma.
Is Shelter Pharma's DeferredTaxAndRevenue too high?
Shelter Pharma's current DeferredTaxAndRevenue is ₹0.0 Mil. Overall, Shelter Pharma has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shelter Pharma's DeferredTaxAndRevenue compare to ZTS?
Shelter Pharma's DeferredTaxAndRevenue of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Drug Manufacturers company?
A good DeferredTaxAndRevenue depends on the Drug Manufacturers industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Shelter Pharma. Shelter Pharma's current DeferredTaxAndRevenue is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shelter Pharma stock overvalued right now?
Based on GuruFocus' analysis, Shelter Pharma (BOM:543963) is currently considered Possible Value Trap. The stock's GF Value™ is ₹57.30, compared to a current price of ₹33.77 — trading 41.1% below its estimated fair value. The current DeferredTaxAndRevenue is ₹0.0 Mil. Shelter Pharma's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Shelter Pharma (BOM:543963), the current DeferredTaxAndRevenue is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shelter Pharma (BOM:543963) Overvalued in 2026?

Based on GuruFocus' analysis, Shelter Pharma stock appears to be undervalued. The current stock price of ₹33.77 is trading 41.1% below its estimated GF Value™ of ₹57.30. GuruFocus considers Shelter Pharma to be Possible Value Trap.

Key valuation signals for BOM:543963:

  • DeferredTaxAndRevenue: ₹0.0 Mil
  • GF Value™: ₹57.30 vs. price of ₹33.77 (41.1% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the BOM:543963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shelter Pharma Business Description

Address Ashram Road, 5th Floor, 501 Sakar 4, Opposite MJ Library, Paldi, Ellisbridge, Ahmedabad, GJ, IND, 380006
Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in majority of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.
69GF Score

Get the complete analysis for BOM:543963

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹33.77
Price
₹57.30
GF Value